Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1567 entries
Sorted by: Best Match Show Resources per page
[Lesson in mathematics. Irrational and rational numbers].

Kango kyoshitsu. [Nursing classroom]

Chiba S.
PMID: 4496222
Kango Kyoshitsu. 1974 Jun;18(6):44.

No abstract available.

Cite
Chiba S. [Lesson in mathematics. Irrational and rational numbers]. Kango Kyoshitsu. 1974;18(6):44
Chiba, S. (1974). [Lesson in mathematics. Irrational and rational numbers]. Kango kyoshitsu. [Nursing classroom], 18(6), 44.
Chiba, S. "[Lesson in mathematics. Irrational and rational numbers]." Kango kyoshitsu. [Nursing classroom] vol. 18,6 (1974): 44.
Chiba S. [Lesson in mathematics. Irrational and rational numbers]. Kango Kyoshitsu. 1974 Jun;18(6):44. Japanese. PMID: 4496222.
Copy Download .nbib Format: NLM
[Axial transverse tomography applied to diseases of paranasal sinus].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica

Matsuda T, Baba S, Oashi M.
PMID: 5277480
Nihon Igaku Hoshasen Gakkai Zasshi. 1971 Jan;30(10):55-63.

No abstract available.

Cite
Matsuda T, Baba S, Oashi M. [Axial transverse tomography applied to diseases of paranasal sinus]. Nihon Igaku Hoshasen Gakkai Zasshi. 1971;30(10):55-63
Matsuda, T., Baba, S., & Oashi, M. (1971). [Axial transverse tomography applied to diseases of paranasal sinus]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 30(10), 55-63.
Matsuda, T, et al. "[Axial transverse tomography applied to diseases of paranasal sinus]." Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica vol. 30,10 (1971): 55-63.
Matsuda T, Baba S, Oashi M. [Axial transverse tomography applied to diseases of paranasal sinus]. Nihon Igaku Hoshasen Gakkai Zasshi. 1971 Jan;30(10):55-63. Japanese. PMID: 5277480.
Copy Download .nbib Format: NLM
Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case.

Journal of anesthesia

Takenaka M, Iida H, Ohta S, Dohi S.
PMID: 28921070
J Anesth. 1997 Dec;11(4):300-302. doi: 10.1007/BF02480748.

No abstract available.

Cite
Takenaka M, Iida H, Ohta S, et al. Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case. J Anesth. 1997;11(4):300-302doi: 10.1007/BF02480748.
Takenaka, M., Iida, H., Ohta, S., & Dohi, S. (1997). Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case. Journal of anesthesia, 11(4), 300-302. https://doi.org/10.1007/BF02480748
Takenaka, Motoyasu, et al. "Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case." Journal of anesthesia vol. 11,4 (1997): 300-302. doi: https://doi.org/10.1007/BF02480748
Takenaka M, Iida H, Ohta S, Dohi S. Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case. J Anesth. 1997 Dec;11(4):300-302. doi: 10.1007/BF02480748. PMID: 28921070.
Copy Download .nbib Format: NLM
anti-Selective aminofluorination of alkenes with amidines mediated by hypervalent iodine(iii) reagents.

Organic & biomolecular chemistry

Chen H, Kaga A, Chiba S.
PMID: 26426571
Org Biomol Chem. 2016 Jun 28;14(24):5481-5. doi: 10.1039/c5ob01854d. Epub 2015 Oct 01.

anti-Selective aminofluorination of alkenes with amidines was enabled by hypervalent iodine(iii) reagents, affording 4-fluoroalkyl-2-imidazolines. Further reductive ring-opening of the 2-imidazoline moiety could deliver highly functionalized 3-fluoropropane-1,2-diamine derivatives.

Cite
Chen H, Kaga A, Chiba S. anti-Selective aminofluorination of alkenes with amidines mediated by hypervalent iodine(iii) reagents. Org Biomol Chem. 2015;14(24):5481-5doi: 10.1039/c5ob01854d.
Chen, H., Kaga, A., & Chiba, S. (2016). anti-Selective aminofluorination of alkenes with amidines mediated by hypervalent iodine(iii) reagents. Organic & biomolecular chemistry, 14(24), 5481-5. https://doi.org/10.1039/c5ob01854d
Chen, Hui, et al. "anti-Selective aminofluorination of alkenes with amidines mediated by hypervalent iodine(iii) reagents." Organic & biomolecular chemistry vol. 14,24 (2016): 5481-5. doi: https://doi.org/10.1039/c5ob01854d
Chen H, Kaga A, Chiba S. anti-Selective aminofluorination of alkenes with amidines mediated by hypervalent iodine(iii) reagents. Org Biomol Chem. 2016 Jun 28;14(24):5481-5. doi: 10.1039/c5ob01854d. Epub 2015 Oct 01. PMID: 26426571.
Copy Download .nbib Format: NLM
A Proximally Based Sural Fasciocutaneous Flap for the Treatment of Recurrent Peroneal Neuropathy: A Case Report.

Plastic and reconstructive surgery. Global open

Ohta S, Ikeguchi R, Noguchi T, Kaizawa Y, Oda H, Matsuda S.
PMID: 27536494
Plast Reconstr Surg Glob Open. 2016 Jul 21;4(7):e815. doi: 10.1097/GOX.0000000000000825. eCollection 2016 Jul.

Surgical treatment for recurrent, common peroneal neuropathy has not been reported. Herein, we describe a successfully treated case using the proximally based sural fasciocutaneous flap after reneurolysis of the adhesive common peroneal nerve. A 33-year-old man received a neurolysis...

Cite
Ohta S, Ikeguchi R, Noguchi T, et al. A Proximally Based Sural Fasciocutaneous Flap for the Treatment of Recurrent Peroneal Neuropathy: A Case Report. Plast Reconstr Surg Glob Open. 2016;4(7):e815doi: 10.1097/GOX.0000000000000825.
Ohta, S., Ikeguchi, R., Noguchi, T., Kaizawa, Y., Oda, H., & Matsuda, S. (2016). A Proximally Based Sural Fasciocutaneous Flap for the Treatment of Recurrent Peroneal Neuropathy: A Case Report. Plastic and reconstructive surgery. Global open, 4(7), e815. https://doi.org/10.1097/GOX.0000000000000825
Ohta, Souichi, et al. "A Proximally Based Sural Fasciocutaneous Flap for the Treatment of Recurrent Peroneal Neuropathy: A Case Report." Plastic and reconstructive surgery. Global open vol. 4,7 (2016): e815. doi: https://doi.org/10.1097/GOX.0000000000000825
Ohta S, Ikeguchi R, Noguchi T, Kaizawa Y, Oda H, Matsuda S. A Proximally Based Sural Fasciocutaneous Flap for the Treatment of Recurrent Peroneal Neuropathy: A Case Report. Plast Reconstr Surg Glob Open. 2016 Jul 21;4(7):e815. doi: 10.1097/GOX.0000000000000825. eCollection 2016 Jul. PMID: 27536494; PMCID: PMC4977143.
Copy Download .nbib Format: NLM
Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report.

Journal of neurological surgery reports

Sakai N, Ito-Yamashita T, Takahashi G, Baba S, Koizumi S, Yamasaki T, Tokuyama T, Namba H.
PMID: 25083392
J Neurol Surg Rep. 2014 Aug;75(1):e62-6. doi: 10.1055/s-0033-1363505. Epub 2014 Jan 16.

Primary neurolymphomatosis is an extremely rare tumor. We report the case of a 74-year-old patient presenting with dysphagia and hoarseness. Initial contrast-enhanced computed tomography of the head, neck, and chest did not reveal any lesions. His symptoms improved with...

Cite
Sakai N, Ito-Yamashita T, Takahashi G, et al. Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report. J Neurol Surg Rep. 2014;75(1):e62-6doi: 10.1055/s-0033-1363505.
Sakai, N., Ito-Yamashita, T., Takahashi, G., Baba, S., Koizumi, S., Yamasaki, T., Tokuyama, T., & Namba, H. (2014). Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report. Journal of neurological surgery reports, 75(1), e62-6. https://doi.org/10.1055/s-0033-1363505
Sakai, Naoto, et al. "Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report." Journal of neurological surgery reports vol. 75,1 (2014): e62-6. doi: https://doi.org/10.1055/s-0033-1363505
Sakai N, Ito-Yamashita T, Takahashi G, Baba S, Koizumi S, Yamasaki T, Tokuyama T, Namba H. Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report. J Neurol Surg Rep. 2014 Aug;75(1):e62-6. doi: 10.1055/s-0033-1363505. Epub 2014 Jan 16. PMID: 25083392; PMCID: PMC4110151.
Copy Download .nbib Format: NLM
A Monte Carlo study on (223)Ra imaging for unsealed radionuclide therapy.

Medical physics

Takahashi A, Miwa K, Sasaki M, Baba S.
PMID: 27277045
Med Phys. 2016 Jun;43(6):2965-2974. doi: 10.1118/1.4948682.

PURPOSE: Radium-223 ((223)Ra), an α-emitting radionuclide, is used in unsealed radionuclide therapy for metastatic bone tumors. The demand for qualitative (223)Ra imaging is growing to optimize dosimetry. The authors simulated (223)Ra imaging using an in-house Monte Carlo simulation code...

Cite
Takahashi A, Miwa K, Sasaki M, et al. A Monte Carlo study on (223)Ra imaging for unsealed radionuclide therapy. Med Phys. 2016;43(6):2965-2974doi: 10.1118/1.4948682.
Takahashi, A., Miwa, K., Sasaki, M., & Baba, S. (2016). A Monte Carlo study on (223)Ra imaging for unsealed radionuclide therapy. Medical physics, 43(6), 2965-2974. https://doi.org/10.1118/1.4948682
Takahashi, Akihiko, et al. "A Monte Carlo study on (223)Ra imaging for unsealed radionuclide therapy." Medical physics vol. 43,6 (2016): 2965-2974. doi: https://doi.org/10.1118/1.4948682
Takahashi A, Miwa K, Sasaki M, Baba S. A Monte Carlo study on (223)Ra imaging for unsealed radionuclide therapy. Med Phys. 2016 Jun;43(6):2965-2974. doi: 10.1118/1.4948682. PMID: 27277045.
Copy Download .nbib Format: NLM
A comparison of different proportions of a ketamine-propofol mixture administered in a single injection for patients undergoing colonoscopy.

Archives of medical science : AMS

Aydogmus MT, Türk HS, Oba S, Gokalp O.
PMID: 26170850
Arch Med Sci. 2015 Jun 19;11(3):570-6. doi: 10.5114/aoms.2015.52360.

INTRODUCTION: In this study, we aimed to determine the appropriate proportion of ketamine-propofol (ketofol), which was prepared in two different proportions for colonoscopy procedures.MATERIAL AND METHODS: This is a prospective and randomized trial. Group 1 was administered a mixture...

Cite
Aydogmus MT, Türk HS, Oba S, et al. A comparison of different proportions of a ketamine-propofol mixture administered in a single injection for patients undergoing colonoscopy. Arch Med Sci. 2015;11(3):570-6doi: 10.5114/aoms.2015.52360.
Aydogmus, M. T., Türk, H. S., Oba, S., & Gokalp, O. (2015). A comparison of different proportions of a ketamine-propofol mixture administered in a single injection for patients undergoing colonoscopy. Archives of medical science : AMS, 11(3), 570-6. https://doi.org/10.5114/aoms.2015.52360
Aydogmus, Meltem Türkay, et al. "A comparison of different proportions of a ketamine-propofol mixture administered in a single injection for patients undergoing colonoscopy." Archives of medical science : AMS vol. 11,3 (2015): 570-6. doi: https://doi.org/10.5114/aoms.2015.52360
Aydogmus MT, Türk HS, Oba S, Gokalp O. A comparison of different proportions of a ketamine-propofol mixture administered in a single injection for patients undergoing colonoscopy. Arch Med Sci. 2015 Jun 19;11(3):570-6. doi: 10.5114/aoms.2015.52360. PMID: 26170850; PMCID: PMC4495153.
Copy Download .nbib Format: NLM
Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria.

Case reports in hematology

Ninomiya H, Obara N, Niiori-Onishi A, Yokoyama Y, Sakata-Yanagimoto M, Hasegawa Y, Chiba S.
PMID: 26124968
Case Rep Hematol. 2015;2015:673195. doi: 10.1155/2015/673195. Epub 2015 Jun 01.

Chronic kidney disease (CKD) is one of the major manifestations of paroxysmal nocturnal hemoglobinuria (PNH). CKD in PNH is induced mainly by intravascular hemolysis of PNH-affected red blood cells (RBC) missing the glycosylphosphatidylinositol-anchored proteins with complement-regulatory activities, CD55 and...

Cite
Ninomiya H, Obara N, Niiori-Onishi A, et al. Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria. Case Rep Hematol. 2015;2015:673195doi: 10.1155/2015/673195.
Ninomiya, H., Obara, N., Niiori-Onishi, A., Yokoyama, Y., Sakata-Yanagimoto, M., Hasegawa, Y., & Chiba, S. (2015). Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria. Case reports in hematology, 2015673195. https://doi.org/10.1155/2015/673195
Ninomiya, Haruhiko, et al. "Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria." Case reports in hematology vol. 2015 (2015): 673195. doi: https://doi.org/10.1155/2015/673195
Ninomiya H, Obara N, Niiori-Onishi A, Yokoyama Y, Sakata-Yanagimoto M, Hasegawa Y, Chiba S. Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria. Case Rep Hematol. 2015;2015:673195. doi: 10.1155/2015/673195. Epub 2015 Jun 01. PMID: 26124968; PMCID: PMC4466353.
Copy Download .nbib Format: NLM
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.

Oncology letters

Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H.
PMID: 28356963
Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12.

In patients with advanced urothelial cancer (UC), a combination of cisplatin (CDDP) and gemcitabine (GEM) is the most commonly used first-line systematic chemotherapy regimen. Although no standard regime for the treatment of CDDP-resistant UC has been established, GEM-based regimens...

Cite
Miyata Y, Mitsunari K, Akihiro A, et al. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2016;13(2):811-818doi: 10.3892/ol.2016.5484.
Miyata, Y., Mitsunari, K., Akihiro, A., Watanabe, S. I., Matsuo, T., Ohba, K., & Sakai, H. (2017). Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncology letters, 13(2), 811-818. https://doi.org/10.3892/ol.2016.5484
Miyata, Yasuyoshi, et al. "Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer." Oncology letters vol. 13,2 (2017): 811-818. doi: https://doi.org/10.3892/ol.2016.5484
Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12. PMID: 28356963; PMCID: PMC5351343.
Copy Download .nbib Format: NLM
Mold Pectinase Modified with Dialdehyde Derivatives of Dextran and Cellulose.

Bioscience, biotechnology, and biochemistry

Kobayashi M, Chiba Y, Funane K, Ohya S, Kato Y.
PMID: 27281140
Biosci Biotechnol Biochem. 1996 Jan;60(5):794-7. doi: 10.1271/bbb.60.794.

Chemical modification of mold pectinase with dextran- and cellulose-dialdehydes was examined to improve the enzyme characteristics. The modified pectinase with dextran-dialdehyde retained about 50% of the original activity, and more than 80% of the total amino groups were modified....

Cite
Kobayashi M, Chiba Y, Funane K, et al. Mold Pectinase Modified with Dialdehyde Derivatives of Dextran and Cellulose. Biosci Biotechnol Biochem. 1996;60(5):794-7doi: 10.1271/bbb.60.794.
Kobayashi, M., Chiba, Y., Funane, K., Ohya, S., & Kato, Y. (1996). Mold Pectinase Modified with Dialdehyde Derivatives of Dextran and Cellulose. Bioscience, biotechnology, and biochemistry, 60(5), 794-7. https://doi.org/10.1271/bbb.60.794
Kobayashi, M, et al. "Mold Pectinase Modified with Dialdehyde Derivatives of Dextran and Cellulose." Bioscience, biotechnology, and biochemistry vol. 60,5 (1996): 794-7. doi: https://doi.org/10.1271/bbb.60.794
Kobayashi M, Chiba Y, Funane K, Ohya S, Kato Y. Mold Pectinase Modified with Dialdehyde Derivatives of Dextran and Cellulose. Biosci Biotechnol Biochem. 1996 Jan;60(5):794-7. doi: 10.1271/bbb.60.794. PMID: 27281140.
Copy Download .nbib Format: NLM
Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor.

Case reports in dermatology

Shido K, Fujimura T, Kakizaki A, Furudate S, Asano M, Aiba S.
PMID: 27293390
Case Rep Dermatol. 2016 Feb 05;8(1):26-30. doi: 10.1159/000444045. eCollection 2016.

Plexiform fibrohistiocytic tumor (PFT) is a rare mesenchymal neoplasm of intermediate malignant potential with a high local recurrence rate. In this report, we describe a case of PFT on the ear, which showed a dense deposition of periostin (POSTN)...

Cite
Shido K, Fujimura T, Kakizaki A, et al. Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor. Case Rep Dermatol. 2016;8(1):26-30doi: 10.1159/000444045.
Shido, K., Fujimura, T., Kakizaki, A., Furudate, S., Asano, M., & Aiba, S. (2016). Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor. Case reports in dermatology, 8(1), 26-30. https://doi.org/10.1159/000444045
Shido, Kosuke, et al. "Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor." Case reports in dermatology vol. 8,1 (2016): 26-30. doi: https://doi.org/10.1159/000444045
Shido K, Fujimura T, Kakizaki A, Furudate S, Asano M, Aiba S. Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor. Case Rep Dermatol. 2016 Feb 05;8(1):26-30. doi: 10.1159/000444045. eCollection 2016. PMID: 27293390; PMCID: PMC4899637.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1567 entries